Roivant Sciences Ltd. (ROIV) vs Vertex Pharmaceuticals Incorporated (VRTX)

• Roivant Sciences Ltd. ROIV 33.53 ▼ −1.50%
• Vertex Pharmaceuticals Incorporated VRTX 499.39 ▼ −1.84%

Roivant Sciences Ltd. and Vertex Pharmaceuticals Incorporated are both Biotechnology companies. Vertex Pharmaceuticals Incorporated is the larger, with a market value of $129.0B against $24.6B — 5.2× the size. Roivant Sciences Ltd. has negative trailing earnings, so its P/E is not meaningful; Vertex Pharmaceuticals Incorporated trades at 28.8×. Vertex Pharmaceuticals Incorporated grew revenue faster over the last twelve months: 10.2% against −67.6%. Vertex Pharmaceuticals Incorporated has the higher net margin (35.0% vs −3,535.0%) and the higher return on invested capital (24.1% vs −34.5%). Across the 18 metrics below, Vertex Pharmaceuticals Incorporated leads on 16 and Roivant Sciences Ltd. on 2.